# Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered to Infants in Taiwan

> **NCT00688870** · PHASE3 · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 168 (actual)

## Conditions studied

- Vaccines
- Pneumococcal Conjugate Vaccine

## Interventions

- **BIOLOGICAL:** 13-valent pneumococcal conjugate vaccine (13vPnC)
- **BIOLOGICAL:** 7-valent pneumococcal conjugate vaccine (7vPnC)

## Key facts

- **NCT ID:** NCT00688870
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06-05
- **Primary completion:** 2010-01-13
- **Final completion:** 2010-01-13
- **Target enrollment:** 168 (ACTUAL)
- **Last updated:** 2022-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00688870

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00688870, "Study Evaluating A 13-Valent Pneumococcal Conjugate Vaccine Administered to Infants in Taiwan". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00688870. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*